Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Melanoma 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Various Advanced Cancer 1Uveal Melanoma 1Urothelial Cancer 1Stomach Neoplasms 1Microsatellite Unstable Colorectal Cancer 1Mesothelioma 1Colorectal Neoplasms 1Advanced or Metastatic Solid Tumors 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 1Melphalan 1Ipilimumab 1Dacarbazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has announcements × Uveal Melanoma × Ipilimumab × Clear all
NCT03070392 2026-03-17

Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

Immunocore Ltd

Phase 2 Completed
378 enrolled 15 charts 1 FDA
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡